Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Farmacia Hospitalaria
versão On-line ISSN 2171-8695versão impressa ISSN 1130-6343
Resumo
BERNABEU-MARTINEZ, María Ángeles et al. Consensus to identify the dangerous drugs risks in hospital pharmacy services. Farm Hosp. [online]. 2020, vol.44, n.2, pp.51-61. Epub 28-Set-2020. ISSN 2171-8695. https://dx.doi.org/10.7399/fh.11290.
Objective:
To identify the hazards and define the theoretical occupa tional risks arising from the process of handling hazard drugs in hospital pharmacy services on the basis of expert consensus.
Method:
An expert consensus was conducted (nominal group and documentary techniques) using a mixed method of two face-to-face rounds (meeting of participants and approval of proposals) and three masked rounds (individualized review). The analysis was applied to the field of hospital pharmacy. The stages of the process were desig ned using the standardized graphical Business Process Model and Notation.
Results:
A specific flowchart was obtained for the management and tra ceability of hazardous drugs. All general process phases were characte rized. A management chart included operations addressing the reception and storage, compounding, conservation, and dispensation of hazardous drugs in hospital pharmacy services. This chart provides a description of the chemical hazards and exposure routes.
Conclusions:
The hazardous drug process should be integrated in a standard management system to improve the safety of patients and health care professionals. Efficiency can maximized and procedural incidents minimized, thereby ensuring the quality and the safety of hazardous drugs handling in hospital pharmacy services.
Once hazards are identified, risk assessment should be implemented using a systematic and preventative methodology to minimize the risk and seve rity of any adverse event.
Palavras-chave : Hazardous substances; Antineoplastic agents; Cytostatic agents; Occupational health; Quality control; Process assessment; Information management.